SE8303003D0 - Medel for att oka antitumorverkan hos antitumormedel - Google Patents
Medel for att oka antitumorverkan hos antitumormedelInfo
- Publication number
- SE8303003D0 SE8303003D0 SE8303003A SE8303003A SE8303003D0 SE 8303003 D0 SE8303003 D0 SE 8303003D0 SE 8303003 A SE8303003 A SE 8303003A SE 8303003 A SE8303003 A SE 8303003A SE 8303003 D0 SE8303003 D0 SE 8303003D0
- Authority
- SE
- Sweden
- Prior art keywords
- antitumor
- agents
- diltiazem
- acid addition
- agent
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title abstract 7
- 230000000259 anti-tumor effect Effects 0.000 title abstract 4
- 239000003795 chemical substances by application Substances 0.000 title abstract 2
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 abstract 4
- 229960004166 diltiazem Drugs 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 4
- 239000002253 acid Substances 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 230000002708 enhancing effect Effects 0.000 abstract 2
- 210000004881 tumor cell Anatomy 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57091850A JPS58208222A (ja) | 1982-05-28 | 1982-05-28 | 抗腫瘍剤効果増強剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8303003D0 true SE8303003D0 (sv) | 1983-05-27 |
| SE8303003L SE8303003L (sv) | 1983-11-29 |
| SE462076B SE462076B (sv) | 1990-05-07 |
Family
ID=14038043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8303003A SE462076B (sv) | 1982-05-28 | 1983-05-27 | Antitoemoerkomposition innehaallande diltiazem och ett antitoemoermedel som utvaeljs bland vincristin och doxorubicin, samt anvaendning av diltiazem foer framstaellning av ett antitumoermedel med potentierad verkan |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4628047A (sv) |
| JP (1) | JPS58208222A (sv) |
| BE (1) | BE896872A (sv) |
| CH (1) | CH654212A5 (sv) |
| DE (1) | DE3319347A1 (sv) |
| DK (1) | DK239883A (sv) |
| FR (1) | FR2527441B1 (sv) |
| GB (1) | GB2120941B (sv) |
| IT (1) | IT1208480B (sv) |
| NL (1) | NL8301913A (sv) |
| SE (1) | SE462076B (sv) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59231018A (ja) * | 1983-06-10 | 1984-12-25 | Tanabe Seiyaku Co Ltd | 抗脂血剤 |
| FR2593395A1 (fr) * | 1986-01-28 | 1987-07-31 | Corbiere Jerome | Nouvelles compositions pharmaceutiques antiglaucomateuses a base de 3-acetoxy-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepine-4-one ou d'un de ses sels et leur procede d'obtention |
| FR2597750B1 (fr) * | 1986-04-25 | 1989-06-02 | Pf Medicament | Solution aqueuse stable de sulfate de vincristine |
| DE3705117A1 (de) * | 1987-02-18 | 1988-09-01 | Goedecke Ag | Verwendung von benzothiazepin-derivaten, insbesondere diltiazem bei der protektion von lymphozyten |
| US5112954A (en) * | 1988-02-26 | 1992-05-12 | Neorx Corporation | Method of enhancing the effect of cytotoxic agents |
| US5114951A (en) * | 1989-04-11 | 1992-05-19 | Burroughs Wellcome Company | Agents for combating multiple drug resistance |
| JPH04506072A (ja) * | 1989-06-19 | 1992-10-22 | ザ・ウエルカム・ファウンデーション・リミテッド | 癌治療に有用であり、かつ抗ヒスタミン特性を有する医薬 |
| GB8914061D0 (en) * | 1989-06-19 | 1989-08-09 | Wellcome Found | Agents for potentiating the effects of antitumour agents and combating multiple drug resistance |
| GB8914060D0 (en) * | 1989-06-19 | 1989-08-09 | Wellcome Found | Agents for potentiating the effects of antitumour agents and combating multiple drug resistance |
| GB8914040D0 (en) * | 1989-06-19 | 1989-08-09 | Wellcome Found | Agents for potentiating the effects of antitumour agents and combating multiple drug resistance |
| GB8914062D0 (en) * | 1989-06-19 | 1989-08-09 | Wellcome Found | Agents for potentiating the effects of antitumour agents and combating multiple drug resistance |
| US5208238A (en) * | 1989-06-19 | 1993-05-04 | Burroughs Wellcome Company | Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
| CA2030159A1 (en) * | 1989-11-22 | 1991-05-23 | Nahed K. Ahmed | Anti-cancer drug potentiators |
| CA2030160A1 (en) * | 1989-11-22 | 1991-05-23 | Nahed K. Ahmed | Benzothiazepine metastasis treatment |
| JPH0497451U (sv) * | 1991-01-16 | 1992-08-24 | ||
| GB2291279B (en) * | 1994-06-24 | 1998-07-15 | Thomas & Betts Corp | Improvements in or relating to electrical connection apparatus |
| US7108866B1 (en) | 1999-12-10 | 2006-09-19 | Biovall Laboratories International Srl | Chronotherapeutic diltiazem formulations and the administration thereof |
-
1982
- 1982-05-28 JP JP57091850A patent/JPS58208222A/ja active Granted
-
1983
- 1983-05-26 GB GB08314588A patent/GB2120941B/en not_active Expired
- 1983-05-27 CH CH2919/83A patent/CH654212A5/de not_active IP Right Cessation
- 1983-05-27 US US06/498,639 patent/US4628047A/en not_active Expired - Fee Related
- 1983-05-27 DK DK239883A patent/DK239883A/da not_active Application Discontinuation
- 1983-05-27 IT IT8321348A patent/IT1208480B/it active
- 1983-05-27 BE BE0/210868A patent/BE896872A/fr not_active IP Right Cessation
- 1983-05-27 SE SE8303003A patent/SE462076B/sv not_active IP Right Cessation
- 1983-05-27 FR FR8308866A patent/FR2527441B1/fr not_active Expired
- 1983-05-27 DE DE19833319347 patent/DE3319347A1/de active Granted
- 1983-05-30 NL NL8301913A patent/NL8301913A/nl not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2527441B1 (fr) | 1986-05-09 |
| US4628047A (en) | 1986-12-09 |
| BE896872A (fr) | 1983-09-16 |
| DK239883D0 (da) | 1983-05-27 |
| IT1208480B (it) | 1989-07-10 |
| FR2527441A1 (fr) | 1983-12-02 |
| IT8321348A0 (it) | 1983-05-27 |
| JPS6343366B2 (sv) | 1988-08-30 |
| CH654212A5 (de) | 1986-02-14 |
| DE3319347C2 (sv) | 1992-03-19 |
| SE8303003L (sv) | 1983-11-29 |
| GB8314588D0 (en) | 1983-06-29 |
| DE3319347A1 (de) | 1983-12-01 |
| JPS58208222A (ja) | 1983-12-03 |
| GB2120941B (en) | 1986-09-10 |
| NL8301913A (nl) | 1983-12-16 |
| GB2120941A (en) | 1983-12-14 |
| DK239883A (da) | 1983-11-29 |
| SE462076B (sv) | 1990-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8303003L (sv) | Medel for att oka antitumorverkan hos antitumormedel | |
| EP0151989A3 (en) | Means for the treatment of cardiac diseases | |
| ES2055911T3 (es) | Compuesto farmaceutico adelgazante. | |
| IT1177553B (it) | Composti farmacologicamente attivi per il trattamento di affezioni gastrointestinali e procedimento di preparazione | |
| NO832431L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater. | |
| IT1187828B (it) | Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi | |
| NO864879L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser. | |
| NO831610L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive oxicamderivater. | |
| ATE260931T1 (de) | Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität | |
| IT8324035A0 (it) | Cefem composti ad attivita'farmaceutica e procedimenti per laloro preparazione. | |
| SE7902742L (sv) | Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav | |
| NO862373D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. | |
| FR2547503B1 (fr) | Nouveau systeme solvant-auxiliaire de penetration pour l'administration d'agents physiologiquement actifs par administration percutanee | |
| NO863373L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
| DE10299023I1 (de) | Antineoplastisch wirkender und den Antineoplastischen effekt Verstaerkender Wirkstoff | |
| HUP9903679A2 (hu) | Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására | |
| ATE79272T1 (de) | Acth(1-24) enthaltende pharmazeutische zusammensetzungen zur therapie von schockzustaenden und von respiratorischen und herzkreislauf-insuffizienzen. | |
| KR880003973A (ko) | 약리적 활성 화합물 및 용도 | |
| NO832430L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenyleddiksyre-derivater | |
| DK277387A (da) | Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom | |
| NO167801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater. | |
| NO164599C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt 7-d-mandelamido-3-(1-sulfometyl-tetrazol-5-yl)-tiometyl-3-cefem-4-karboksylsyre-mononatriumsalt. | |
| IT1157061B (it) | Sostanza potenziatrice dell'attivita di antibiotici suoi sali e procedimenti per la loro preparazione | |
| DE3367216D1 (de) | 3-deazaguanine sulphonic acid salts | |
| IT8522275A0 (it) | Uso farmaceutico dellhacido (1-fenilmetil-5-idrossi-1h-indazol3-il)-ossiacetico e dei suoi sali di addizione basica farmaceuticamente accettabili, composizioni farmaceutiche che licontengono. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8303003-1 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 8303003-1 Format of ref document f/p: F |